Research Article
Open Access
Phenotypic proteomic profiling identifies a landscape of targets for circadian clock–modulating compounds
View ORCID ProfileSandipan Ray Correspondence email, Radoslaw Lach, Kate J Heesom, Utham K Valekunja, View ORCID ProfileVesela Encheva, Ambrosius P Snijders, View ORCID ProfileAkhilesh B Reddy Correspondence email
Sandipan Ray
1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Radoslaw Lach
3The Francis Crick Institute, London, UK
Kate J Heesom
4Proteomics Facility, University of Bristol, Bristol, UK
Utham K Valekunja
1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Vesela Encheva
3The Francis Crick Institute, London, UK
Ambrosius P Snijders
3The Francis Crick Institute, London, UK
Akhilesh B Reddy
1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Published 2 December 2019. DOI: 10.26508/lsa.201900603
Protein targets of circadian drugs
Sandipan Ray, Radoslaw Lach, Kate J Heesom, Utham K Valekunja, Vesela Encheva, Ambrosius P Snijders, Akhilesh B Reddy
Life Science Alliance Dec 2019, 2 (6) e201900603; DOI: 10.26508/lsa.201900603
In this Issue
Volume 2, No. 6
December 2019
Advertisement
Jump to section
Related Articles
- No related articles found.